Matinas BioPharma Holdings, Inc.
10-K
March 31, 2026
Key Highlights
- Clinical-stage biotech focused on proprietary lipid nanocrystal (LNC) drug deliv...
- Actively seeking a buyer, merger partner, or intellectual property licensing dea...
- Strategic pivot to a distressed asset model following the collapse of MAT2203 li...
Read Analysis
🤖 AI Generated